Announced Mon, 27 Apr · 20:23 IST
Independent Director appointment approved via postal ballot
Management Changes View source PDF
EMCURE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
+5.9%1-day move
₹1630.60
prior close
₹1642.00
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+2.1+1.6+0.8+1.6+5.9+4.0+10.3+3.6+2.4+0.9+6.5+5.2+13.0—
Up moveDown movePending
AI summary
Members of Emcure Pharmaceuticals approved the appointment of Mr. C S Muralidharan (DIN: 00014740) as an Independent Director through a postal ballot via remote e-voting. The appointment is for a first term of 3 consecutive years effective April 1, 2026. E-voting concluded on April 24, 2026, and results were announced on April 27, 2026. He is not debarred by SEBI and is not related to any existing Director or KMP.
Likely market impact
Routine governance update; reinforces board independence with no material impact expected on stock price.